2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.

Bender AM, Parr LC, Livingston WB, Lindsley CW, Merryman WD

DOI: 10.1021/acs.jmedchem.3c01178
Published: 2023 Aug 24
Container: Journal of medicinal chemistry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.3c01178,
  title = {2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.},
  author = {Bender AM and Parr LC and Livingston WB and Lindsley CW and Merryman WD},
  year = {2023},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/acs.jmedchem.3c01178},
  url = {https://doi.org/10.1021/acs.jmedchem.3c01178}
}

RIS

TY  - JOUR
TI  - 2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.
AU  - Bender AM
AU  - Parr LC
AU  - Livingston WB
AU  - Lindsley CW
AU  - Merryman WD
PY  - 2023
JO  - Journal of medicinal chemistry
DO  - 10.1021/acs.jmedchem.3c01178
UR  - https://doi.org/10.1021/acs.jmedchem.3c01178
ER  -

APA

AM, B., LC, P., WB, L., CW, L., & WD, M. (2023). 2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.3c01178

Source records

pubmed · retrieved 2026-09-27T13:21:41.080Z